Ubiquitin-Related Roles of β-Arrestins in Endocytic Trafficking and Signal Transduction

Journal of Cellular Physiology

Volumn 231, Issue 10, 2016, Pages 2071-2080

  Jean Charles, Pierre Yves ^a   Rajiv, Vishwaesh ^a   Shenoy, Sudha K ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; ANDROGEN RECEPTOR; APOPTOSIS SIGNAL REGULATING KINASE 1; BETA ARRESTIN; BETA ARRESTIN 1; BETA ARRESTIN 2; CYCLIC AMP PHOSPHODIESTERASE; G PROTEIN COUPLED RECEPTOR KINASE 2; NOTCH RECEPTOR; PROTEIN P53; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3;

AUTOPHAGOSOME; CELL MIGRATION; ENDOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84975062691     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25317     Document Type: Review

References (112)

1. Alonso V, Friedman PA. 2013. Minireview: Ubiquitination-regulated G protein-coupled receptor signaling and trafficking. Mol Endocrinol 27:558–572.
2. Alonso V, Magyar CE, Wang B, Bisello A, Friedman PA. 2011. Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting. J Bone Miner Res 26:2923–2934.
3. Alvaro CG, O'Donnell AF, Prosser DC, Augustine AA, Goldman A, Brodsky JL, Cyert MS, Wendland B, Thorner J. 2014. Specific alpha-arrestins negatively regulate Saccharomyces cerevisiae pheromone response by down-modulating the G-protein-coupled receptor Ste2. Mol Cell Biol 34:2660–2681.
4. Amerik AY, Hochstrasser M. 2004. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695:189–207.
5. Aubry L, Klein G. 2013. True arrestins and arrestin-fold proteins: A structure-based appraisal. Prog Mol Biol Transl Sci 118:21–56.
6. Barak LS, Ferguson SS, Zhang J, Caron MG. 1997. A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272:27497–27500.
7. Becuwe M, Vieira N, Lara D, Gomes-Rezende J, Soares-Cunha C, Casal M, Haguenauer-Tsapis R, Vincent O, Paiva S, Leon S. 2012. A molecular switch on an arrestin-like protein relays glucose signaling to transporter endocytosis. J Cell Biol 196:247–259.
8. Berthouze M, Venkataramanan V, Li Y, Shenoy SK. 2009. The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J 28:1684–1696.
9. Bhandari D, Trejo J, Benovic JL, Marchese A. 2007. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 282:36971–36979.
10. Boularan C, Scott MG, Bourougaa K, Bellal M, Esteve E, Thuret A, Benmerah A, Tramier M, Coppey-Moisan M, Labbe-Jullie C, Fahraeus R, Marullo S. 2007. Beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proc Natl Acad Sci USA 104:18061–18066.
11. Busillo JM, Armando S, Sengupta R, Meucci O, Bouvier M, Benovic JL. 2010. Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 285:7805–7817.
12. Cao W, Luttrell LM, Medvedev AV, Pierce KL, Daniel KW, Dixon TM, Lefkowitz RJ, Collins S. 2000. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 275:38131–38134.
13. Charest PG, Terrillon S, Bouvier M. 2005. Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET. EMBO Rep 6:334–340.
14. Christensen GL, Kelstrup CD, Lyngso C, Sarwar U, Bogebo R, Sheikh SP, Gammeltoft S, Olsen JV, Hansen JL. 2010. Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 9:1540–1553.
15. D'Andrea A, Pellman D. 1998. Deubiquitinating enzymes: A new class of biological regulators. Crit Rev Biochem Mol Biol 33:337–352.
16. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. 2007. Beta-arrestins and cell signaling. Annu Rev Physiol 69:483–510.
17. Dikic I, Wakatsuki S, Walters KJ. 2009. Ubiquitin-binding domains—From structures to functions. Nat Rev Mol Cell Biol 10:659–671.
18. Dores MR, Lin HNJG, Mendez F, Trejo J. 2015. The alpha-arrestin ARRDC3 mediates ALIX ubiquitination and G protein-coupled receptor lysosomal sorting. Mol Biol Cell 26:4660–4673.
19. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, Lefkowitz RJ. 2006. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol chem 281:10856–10864.
20. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, Lefkowitz RJ, Larsson O. 2005. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase. J Biol Chem 280:24412–24419.
21. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, Girnita A, Lefkowitz RJ, Larsson O. 2007. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem 282:11329–11338.
22. Green SM, Mostaghel EA, Nelson PS. 2012. Androgen action and metabolism in prostate cancer. Mol Cell Endocrinol 360:3–13.
23. Groer CE, Schmid CL, Jaeger AM, Bohn LM. 2011. Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem 286:31731–31741.
24. Gurevich VV, Gurevich EV. 2013. Structural determinants of arrestin functions. Prog Mol Biol Transl Sci 118:57–92.
25. Han SO, Kommaddi RP, Shenoy SK. 2013. Distinct roles for beta-arrestin2 and arrestin-domain-containing proteins in beta2 adrenergic receptor trafficking. EMBO Rep 14:164–171.
26. Han SO, Xiao K, Kim J, Wu JH, Wisler JW, Nakamura N, Freedman NJ, Shenoy SK. 2012. MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound beta(2)-adrenergic receptors. J Cell Biol 199:817–830.
27. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, Shenoy SK, Gregory SG, Ahn S, Duckett DR, Lefkowitz RJ. 2011. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta- arrestin-1. Nature 477:349–353.
28. Hasdemir B, Bunnett NW, Cottrell GS. 2007. Hepatocyte growth factor-regulated tyrosine kinase substrate (HRS) mediates post-endocytic trafficking of protease-activated receptor and calcitonin receptor-like receptor. J Biol Chem 282:29646–29657.
29. Henry AG, Hislop JN, Grove J, Thorn K, Marsh M, von Zastrow M. 2012. Regulation of endocytic clathrin dynamics by cargo ubiquitination. Dev Cell 23:519–532.
30. Herranz S, Rodriguez JM, Bussink HJ, Sanchez-Ferrero JC, Arst HN, Jr., Penalva MA, Vincent O. 2005. Arrestin-related proteins mediate pH signaling in fungi. Proc Natl Acad Sci USA 102:12141–12146.
31. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425–479.
32. Hicke L. 2001. A new ticket for entry into budding vesicles-ubiquitin. Cell 106:527–530.
33. Hislop JN, von Zastrow M. 2011. Role of ubiquitination in endocytic trafficking of G-protein-coupled receptors. Traffic 12:137–148.
34. Hochstrasser M. 2009. Origin and function of ubiquitin-like proteins. Nature 458:422–429.
35. Hori K, Sen A, Kirchhausen T, Artavanis-Tsakonas S. 2012. Regulation of ligand-independent Notch signal through intracellular trafficking. Commun Integr Biol 5:374–376.
36. Hu W, Feng Z, Levine AJ. 2012. The regulation of multiple p53 stress responses is mediated through M DM2. Genes Cancer 3:199–208.
37. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y. 1997. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90–94.
38. Jaeger WC, Seeber RM, Eidne KA, Pfleger KD. 2014. Molecular determinants of orexin receptor-arrestin-ubiquitin complex formation. Br J Pharmacol 171:364–374.
39. Katzmann DJ, Babst M, Emr SD. 2001. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 106:145–155.
40. Kessler BM, Edelmann MJ. 2011. PTMs in conversation: Activity and function of deubiquitinating enzymes regulated via post-translational modifications. Cell Biochem Biophys 60:21–38.
41. Kim YJ, Hofmann KP, Ernst OP, Scheerer P, Choe HW, Sommer ME. 2013. Crystal structure of pre-activated arrestin p44. Nature 497:142–146.
42. Komander D, Rape M. 2012. The ubiquitin code. Annu Rev Biochem 81:203–229.
43. Kommaddi RP, Jean-Charles PY, Shenoy SK. 2015. Phosphorylation of the deubiquitinase USP20 by protein kinase A regulates post-endocytic trafficking of beta2 adrenergic receptors to autophagosomes during physiological stress. J Biol Chem 290:8888–8903.
44. Kommaddi RP, Shenoy SK. 2013. Arrestins and protein ubiquitination. Prog Mol Biol Transl Sci 118:175–204.
45. Krasel C, Bunemann M, Lorenz K, Lohse MJ. 2005. Beta-arrestin binding to the beta2-adrenergic receptor requires both receptor phosphorylation and receptor activation. J Biol Chem 280:9528–9535.
46. Lakshmikanthan V, Zou L, Kim JI, Michal A, Nie Z, Messias NC, Benovic JL, Daaka Y. 2009. Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proce Natl Acad Sci USA 106:9379–9384.
47. Lefkowitz RJ. 2013. Arrestins come of age: A personal historical perspective. Prog Mol Biol Transl Sci 118:3–18.
48. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by beta-arrestins. Science 308:512–517.
49. Li X, Baillie GS, Houslay MD. 2009. Mdm2 directs the ubiquitination of beta-arrestin- sequestered cAMP phosphodiesterase-4 D5. J Biol Chem 284:16170–16182.
50. Lin CH, MacGurn JA, Chu T, Stefan CJ, Emr SD. 2008. Arrestin-related ubiquitin-ligase adaptors regulate endocytosis and protein turnover at the cell surface. Cell 135:714–725.
51. Lin FT, Daaka Y, Lefkowitz RJ. 1998. Beta-arrestins regulate mitogenic signaling and clathrin- mediated endocytosis of the insulin-like growth factor I receptor. J Biol Chem 273:31640–31643.
52. Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. 2002. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J 21:4037–4048.
53. Lu PJ, Zhou XZ, Shen M, Lu KP. 1999. Function of WW domains as phosphoserine- or phosphothreonine-binding modules. Science 283:1325–1328.
54. Lukashchuk N, Vousden KH. 2007. Ubiquitination and degradation of mutant p53. Mol Cell Biol 27:8284–8295.
55. Luttrell LM, Miller WE. 2013. Arrestins as regulators of kinases and phosphatases. Prog Mol Biol Transl Sci 118:115–147.
56. MacGurn JA, Hsu PC, Emr SD. 2012. Ubiquitin and membrane protein turnover: From cradle to grave. Annu Rev Biochem 81:231–259.
57. Malik R, Marchese A. 2010. Arrestin-2 interacts with the endosomal sorting complex required for transport machinery to modulate endosomal sorting of CX CR4. Mol Biol Cell 21:2529–2541.
58. Marchese A, Benovic JL. 2001. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276:45509–45512.
59. Marchese A, Raiborg C, Santini F, Keen JH, Stenmark H, Benovic JL. 2003. The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CX CR4. Dev Cell 5:709–722.
60. Marchese A, Trejo J. 2013. Ubiquitin-dependent regulation of G protein-coupled receptor trafficking and signaling. Cell Signal 25:707–716.
61. Mariggio S, Garcia-Hoz C, Sarnago S, De Blasi A, Mayor F, Jr., Ribas C. 2006. Tyrosine phosphorylation of G-protein-coupled-receptor kinase 2 (GRK2) by c-Src modulates its interaction with Galphaq. Cell Signal 18:2004–2012.
62. Metzger MB, Hristova VA, Weissman AM. 2012. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci 125:531–537.
63. Milano SK, Kim YM, Stefano FP, Benovic JL, Brenner C. 2006. Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem 281:9812–9823.
64. Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M, Nanoff C. 2006. The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol 69:1083–1094.
65. Mines MA, Goodwin JS, Limbird LE, Cui FF, Fan GH. 2009. Deubiquitination of CXCR4 by USP14 is critical for both CXCL12-induced CXCR4 degradation and chemotaxis but not ERK ativation. J Biol Chem 284:5742–5752.
66. Mukhopadhyay D, Riezman H. 2007. Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315:201–205.
67. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. 2005. A genomic and functional inventory of deubiquitinating enzymes. Cell 123:773–786.
68. Nikko E, Pelham HR. 2009. Arrestin-mediated endocytosis of yeast plasma membrane transporters. Traffic 10:1856–1867.
69. Nilius B, Voets T. 2013. The puzzle of TRPV4 channelopathies. EMBO Rep 14:152–163.
70. Nobles KN, Xiao K, Ahn S, Shukla AK, Lam CM, Rajagopal S, Strachan RT, Huang TY, Bressler EA, Hara MR, Shenoy SK, Gygi SP, Lefkowitz RJ. 2011. Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal 4:ra51.
71. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 1999. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem 274:32248–32257.
72. Orlowski J, Grinstein S. 2011. Na+/H+ exchangers. Compr Physiol 1:2083–2100.
73. Patwari P, Emilsson V, Schadt EE, Chutkow WA, Lee S, Marsili A, Zhang Y, Dobrin R, Cohen DE, Larsen PR, Zavacki AM, Fong LG, Young SG, Lee RT. 2011. The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab 14:671–683.
74. Penela P, Elorza A, Sarnago S, Mayor F, Jr. 2001. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J 20:5129–5138.
75. Perroy J, Pontier S, Charest PG, Aubry M, Bouvier M. 2004. Real-time monitoring of ubiquitination in living cells by BRET. Nat Methods 1:203–208.
76. Philipp M, Evron T, Caron MG. 2013. The role of arrestins in development. Prog Mol Biol Transl Sci 118:225–242.
77. Piper RC, Dikic I, Lukacs GL. 2014. Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb Perspect Biol 6:a016808.
78. Puca L, Chastagner P, Meas-Yedid V, Israel A, Brou C. 2013. Alpha-arrestin 1 (ARRDC1) and beta-arrestins cooperate to mediate Notch degradation in mammals. J Cell Sci 126:4457–4468.
79. Raiborg C, Stenmark H. 2009. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458:445–452.
80. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. 2012. Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197.
81. Reyes-Turcu FE, Ventii KH, Wilkinson KD. 2009. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78:363–397.
82. Salcedo A, Mayor F, Jr., Penela P. 2006. Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2. EMBO J 25:4752–4762.
83. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S, Marullo S, Benmerah A. 2002. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 277:37693–37701.
84. Shenoy SK. 2007. Seven-transmembrane receptors and ubiquitination. Circ Res 100:1142–1154.
85. Shenoy SK, Barak LS, Xiao K, Ahn S, Berthouze M, Shukla AK, Luttrell LM, Lefkowitz RJ. 2007. Ubiquitination of beta-arrestin links seven-transmembrane receptor endocytosis and ERK activation. J Biol Chem 282:29549–29562.
86. Shenoy SK, Lefkowitz RJ. 2003. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. J Biol Chem 278:14498–14506.
87. Shenoy SK, Lefkowitz RJ. 2005. Receptor-specific ubiquitination of beta-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J Biol Chem 280:15315–15324.
88. Shenoy SK, Lefkowitz RJ. 2011. Beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32:521–533.
89. Shenoy SK, McDonald PH, Kohout TA, Lefkowitz RJ. 2001. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin. Science 294:1307–1313.
90. Shenoy SK, Modi AS, Shukla AK, Xiao K, Berthouze M, Ahn S, Wilkinson KD, Miller WE, Lefkowitz RJ. 2009. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci USA 106:6650–6655.
91. Shenoy SK, Xiao K, Venkataramanan V, Snyder PM, Freedman NJ, Weissman AM. 2008. Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem 283:22166–22176.
92. Shukla AK, Kim J, Ahn S, Xiao K, Shenoy SK, Liedtke W, Lefkowitz RJ. 2010. Arresting a transient receptor potential (TRP) channel: Beta-arrestin 1 mediates ubiquitination and functional down-regulation of TRPV4. J Biol Chem 285:30115–30125.
93. Shukla AK, Manglik A, Kruse AC, Xiao K, Reis RI, Tseng WC, Staus DP, Hilger D, Uysal S, Huang LY, Paduch M, Tripathi-Shukla P, Koide A, Koide S, Weis WI, Kossiakoff AA, Kobilka BK, Lefkowitz RJ. 2013. Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497:137–141.
94. Shukla AK, Xiao K, Lefkowitz RJ. 2011. Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 36:457–469.
95. Simonin A, Fuster D. 2010. Nedd 4–1 and beta-arrestin-1 are key regulators of Na+/H+ exchanger 1 ubiquitylation, endocytosis, and function. J Biol Chem 285:38293–38303.
96. Snyder JC, Rochelle LK, Lyerly HK, Caron MG, Barak LS. 2013. Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network. J Biol Chem 288:10286–10297.
97. Sommer ME, Farrens DL, McDowell JH, Weber LA, Smith WC. 2007. Dynamics of arrestin-rhodopsin interactions: Loop movement is involved in arrestin activation and receptor binding. J Biol Chem 282:25560–25568.
98. Tian X, Kang DS, Benovic JL. 2014. Beta-arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol 219:173–186.
99. Tobiume K, Saitoh M, Ichijo H. 2002. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 191:95–104.
100. Varshavsky A. 2012. The ubiquitin system, an immense realm. Annu Rev Biochem 81:167–176.
101. Violin JD, Lefkowitz RJ. 2007. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28:416–422.
102. Wang P, Gao H, Ni Y, Wang B, Wu Y, Ji L, Qin L, Ma L, Pei G. 2003. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J Biol Chem 278:6363–6370.
103. Wei C, Lin M, Jinjun B, Su F, Dan C, Yan C, Jie Y, Jin Z, Zi-Chun H, Wu Y. 2015. Involvement of general control nonderepressible kinase 2 in cancer cell apoptosis by posttranslational mechanisms. Mol Biol Cell 26:1044–1057.
104. Wilkinson KD. 1997. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J 11:1245–1256.
105. Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, Lefkowitz RJ. 2007. A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci USA 104:16657–16662.
106. Xiao K, Shenoy SK. 2011. Beta2-adrenergic receptor lysosomal trafficking is regulated by ubiquitination of lysyl residues in two distinct receptor domains. J Biol Chem 286:12785–12795.
107. Xiao K, Shenoy SK, Nobles K, Lefkowitz RJ. 2004. Activation-dependent conformational changes in {beta}-arrestin 2. J Biol Chem 279:55744–55753.
108. Xiao K, Sun J, Kim J, Rajagopal S, Zhai B, Villen J, Haas W, Kovacs JJ, Shukla AK, Hara MR, Hernandez M, Lachmann A, Zhao S, Lin Y, Cheng Y, Mizuno K, Ma'ayan A, Gygi SP, Lefkowitz RJ. 2010. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci USA 107:15299–15304.
109. Yang F, Yu X, Liu C, Qu CX, Gong Z, Liu HD, Li FH, Wang HM, He DF, Yi F, Song C, Tian CL, Xiao KH, Wang JY, Sun JP. 2015. Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR. Nat Commun 6:8202.
110. Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, Bobrovnikova-Marjon E, Diehl JA, Ron D, Koumenis C. 2010. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. EMBO J 29:2082–2096.
111. Zhang Z, Hao J, Zhao Z, Ben P, Fang F, Shi L, Gao Y, Liu J, Wen C, Luo L, Yin Z. 2009. Beta-arrestins facilitate ubiquitin-dependent degradation of apoptosis signal-regulating kinase 1 (ASK1) and attenuate H2O2-induced apoptosis. Cell Signal 21:1195–1206.
112. Zheng M, Zhang X, Guo S, Zhang X, Choi HJ, Lee MY, Kim KM. 2015. PKCbetaII inhibits the ubiquitination of beta-arrestin2 in an autophosphorylation-dependent manner. FEBS Lett 589:3929–3937.